Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NAPE-PLD inhibitors(N-acyl phosphatidylethanolamine phospholipase D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H31N5O2 |
InChIKeyGFHJYPQZBBHOCC-UXHICEINSA-N |
CAS Registry2393840-15-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Preclinical | NL | 11 May 2020 |